Step 1 topics → Microbiology → Human Papillomavirus

Human Papillomavirus

USMLE Step 1 trap: Confuses the low-risk wart-causing HPV subtypes (6, 11) with the high-risk oncogenic subtypes (16, 18). HPV types 6 and 11 cause benign genital warts (condylomata acuminata), while types 16 and 18 are high-risk oncogenic strains associated with cervical, oropharyngeal, and anogenital cancers.

Human papillomavirus is a non-enveloped, double-stranded DNA virus that USMLE Step 1 tests from multiple angles, and the oncogenic mechanism is the most consistently misunderstood: HPV doesn't activate oncogenes — it destroys tumor suppressors. E6 degrades p53, eliminating apoptotic signaling. E7 inactivates Rb, releasing E2F and driving unchecked cell cycle progression. Students who describe HPV as 'activating growth genes' will get the mechanism question wrong every time. The low-risk/high-risk split (6, 11 = warts; 16, 18 = cervical and oropharyngeal cancer) and the koilocyte finding on Pap smear round out the high-yield content the exam targets.

The trickiest part of this topic is the oncogenic mechanism. Most students know HPV causes cancer but misremember how. HPV doesn't activate oncogenes like other carcinogens — it works by destroying tumor suppressors. E6 degrades p53 (preventing apoptosis), and E7 inactivates Rb (releasing E2F and driving unchecked cell cycle entry). That mechanistic detail is exactly what USMLE Step 1 passages will test, often in a vignette describing a young woman with cervical dysplasia asking you to explain the molecular basis.

Vaccination questions are also high yield and commonly trip students up. The 9-valent Gardasil covers strains 6, 11, 16, 18, 31, 33, 45, 52, and 58 — but it does not cover every oncogenic type, so Pap smear screening remains necessary post-vaccination. Recommended vaccination is ideally at age 11–12 (can start at 9), with catch-up through age 26, and shared decision-making up to age 45. Don't conflate vaccination with elimination of cancer risk.

From real student decks
78%have cards covering this topic
57%have mature cards
1median lapses in 14 days

Common misconceptions

Common mistake
Wrong: HPV types 16 and 18 cause genital warts.
Right: HPV types 6 and 11 cause benign genital warts (condylomata acuminata), while types 16 and 18 are high-risk oncogenic strains associated with cervical, oropharyngeal, and anogenital cancers.
Types 6 and 11 are low-risk strains that cause benign condylomata acuminata (genital warts) — they rarely integrate into the host genome and don't drive malignant transformation. Types 16 and 18 are high-risk oncogenic strains responsible for the majority of cervical cancers and a growing proportion of oropharyngeal and anal cancers. Swapping these on the exam is one of the most common single-point errors in this topic — anchor it by remembering '6 and 11 = warts, 16 and 18 = cancer.'
Common mistake
Wrong: HPV causes cancer by inserting an oncogene that activates growth factor receptors.
Right: HPV oncoproteins E6 and E7 inactivate tumor suppressors p53 and Rb respectively, removing cell cycle checkpoints and enabling malignant transformation.
HPV oncogenesis is not about turning on a growth-promoting gene — it's about turning off the brakes. E6 binds and targets p53 for ubiquitin-mediated degradation, eliminating apoptotic signaling in cells with DNA damage. E7 binds and inactivates Rb, freeing transcription factor E2F to push cells through the G1/S checkpoint uncontrolled. Understanding this tumor-suppressor-inactivation model also explains why HPV-related cancers resemble Li-Fraumeni (p53 loss) and familial retinoblastoma (Rb loss) at the molecular level.
Common mistake
Wrong: The HPV vaccine protects against all HPV strains and eliminates the need for Pap smears.
Right: The 9-valent HPV vaccine covers the most common high- and low-risk strains but not all oncogenic types; Pap smear screening remains necessary even in vaccinated individuals.
The 9-valent HPV vaccine is highly effective but covers a defined set of strains — it does not eliminate all oncogenic HPV types, so vaccinated individuals can still develop HPV-related dysplasia from uncovered strains. Pap smear and co-testing guidelines apply regardless of vaccination status. On USMLE Step 1, any answer choice suggesting the vaccine makes cervical screening unnecessary is wrong; vaccination and screening are complementary, not interchangeable.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know which HPV subtypes are low-risk (6 and 11, causing genital warts) versus high-risk (16 and 18, causing cervical, oropharyngeal, and anal cancers), and be able to match subtype to clinical presentation in a vignette.
  2. Understand the molecular mechanism of HPV oncogenesis: E6 inactivates p53 and E7 inactivates Rb, and know what downstream consequences each produces (loss of apoptosis vs. uncontrolled cell cycle entry).
  3. Recognize koilocytes on cytology as the histologic hallmark of HPV infection and understand how Pap smear, colposcopy, and HPV co-testing fit into the cervical cancer screening algorithm.
  4. Know the HPV vaccine (9-valent Gardasil), which strains it covers, the recommended age range for vaccination, and — critically — why Pap smear screening must continue even in vaccinated patients.

Can you avoid these mistakes?

A 22-year-old woman presents with multiple soft, flesh-colored genital lesions. Biopsy shows koilocytes. Which HPV subtypes are most likely responsible, and why are these considered low-risk compared to other HPV strains?
A research vignette describes a cervical cancer cell line in which a viral protein has caused near-complete loss of p53 activity and constitutive E2F activation. Which two HPV oncoproteins are responsible, and what are their respective molecular targets?
A 30-year-old vaccinated woman comes in for routine gynecologic care and asks whether she still needs Pap smears since she received the HPV vaccine at age 14. What is the correct counseling, and what is the reasoning behind continuing screening?
On a Pap smear, you see squamous cells with enlarged, irregular nuclei surrounded by a clear halo of cytoplasm. What are these cells called, what do they indicate, and which high-risk HPV subtypes are most associated with progression to cervical carcinoma?

Related topics

Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →